INMD
InMode Ltd. NASDAQ$14.40
Mkt Cap $912.4M
52w Low $12.72
41.8% of range
52w High $16.74
50d MA $13.84
200d MA $14.47
P/E (TTM)
9.9x
EV/EBITDA
5.9x
P/B
1.4x
Debt/Equity
0.0x
ROE
29.0%
P/FCF
11.3x
RSI (14)
—
ATR (14)
—
Beta
2.12
50d MA
$13.84
200d MA
$14.47
Avg Volume
1.1M
About
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tighte…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | BMO | 0.42 | 0.46 | +10.5% | 14.62 | +0.9% | -2.6% | -2.2% | -2.2% | -1.0% | -1.1% | — |
| Nov 5, 2025 | BMO | 0.35 | 0.38 | +8.3% | 14.53 | -1.6% | -0.6% | -0.6% | +0.5% | -0.1% | +0.6% | — |
| Jul 30, 2025 | BMO | 0.43 | 0.47 | +9.3% | 13.90 | -0.6% | -1.7% | -1.2% | +1.2% | +1.7% | +0.6% | — |
| Apr 28, 2025 | BMO | 0.33 | 0.31 | -6.1% | 14.26 | -0.4% | +1.1% | -1.1% | +3.1% | +2.2% | -0.1% | — |
| Feb 4, 2025 | BMO | 0.50 | 0.42 | -16.0% | 17.50 | +0.7% | +2.6% | +4.3% | +3.1% | +5.9% | +6.2% | — |
| Oct 30, 2024 | BMO | 0.63 | 0.70 | +11.1% | 17.87 | +0.1% | -4.4% | -3.4% | -2.7% | +0.2% | +7.8% | — |
| Aug 1, 2024 | BMO | 0.38 | 0.34 | -10.5% | 16.57 | -3.1% | +3.6% | -0.5% | +2.1% | -0.1% | +1.3% | — |
| May 2, 2024 | BMO | 0.41 | 0.32 | -22.0% | 17.36 | +2.1% | +1.6% | +7.4% | +6.6% | +5.4% | +5.8% | — |
| Feb 13, 2024 | BMO | 0.67 | 0.71 | +6.0% | 23.67 | +1.4% | -3.3% | +0.4% | -3.7% | -11.4% | -12.0% | — |
| Nov 2, 2023 | BMO | 0.64 | 0.61 | -4.7% | 21.76 | +0.3% | -1.3% | -5.9% | -9.6% | -8.1% | -9.5% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17 | Canaccord Genuity | Maintains | Hold → Hold | — | $14.48 | $14.31 | -1.2% | -1.2% | +0.6% | -0.8% | -0.3% | -0.8% |
| Nov 6 | UBS | Maintains | Neutral → Neutral | — | $14.53 | $14.30 | -1.6% | -0.6% | -0.6% | +0.5% | -0.1% | +0.6% |
| Oct 10 | Needham | Maintains | Hold → Hold | — | $15.89 | $16.00 | +0.7% | -3.9% | -3.7% | -2.8% | -3.9% | -4.2% |
| Oct 10 | Canaccord Genuity | Maintains | Hold → Hold | — | $15.89 | $16.00 | +0.7% | -3.9% | -3.7% | -2.8% | -3.9% | -4.2% |
| Jul 30 | Needham | Maintains | Hold → Hold | — | $14.31 | $14.02 | -2.0% | -2.9% | -4.5% | -4.0% | -1.7% | -1.3% |
| Jul 30 | Barclays | Maintains | Overweight → Overweight | — | $14.31 | $14.02 | -2.0% | -2.9% | -4.5% | -4.0% | -1.7% | -1.3% |
| Jul 11 | Canaccord Genuity | Maintains | Hold → Hold | — | $15.18 | $15.07 | -0.7% | -3.1% | -2.9% | -6.1% | -6.1% | -7.1% |
| Apr 30 | Barclays | Maintains | Overweight → Overweight | — | $14.42 | $14.23 | -1.3% | -2.2% | +1.9% | +1.0% | -1.2% | -0.8% |
| Apr 29 | Canaccord Genuity | Maintains | Hold → Hold | — | $14.26 | $14.21 | -0.4% | +1.1% | -1.1% | +3.1% | +2.2% | -0.1% |
| Apr 29 | BTIG | Downgrade | Buy → Neutral | — | $14.26 | $14.21 | -0.4% | +1.1% | -1.1% | +3.1% | +2.2% | -0.1% |
Data updated apr 25, 2026 3:41pm
· Source: massive.com